Overview of the 2022 WHO classification of thyroid neoplasms
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …
Emerging biomarkers in thyroid practice and research
Simple Summary Tumor biomarkers are molecules at genetic or protein level, or certain
evaluable characteristics. These help in perfecting patient management. Over the past …
evaluable characteristics. These help in perfecting patient management. Over the past …
A shift in molecular drivers of papillary thyroid carcinoma following the 2017 World health organization classification: characterization of 554 consecutive tumors with …
Most studies for comprehensive molecular profiling of papillary thyroid carcinoma (PTC)
have been performed before the 2017 World Health Organization (WHO) classification, in …
have been performed before the 2017 World Health Organization (WHO) classification, in …
Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing …
DICER1 gene encodes an RNaseIII endoribonuclease essential for the cleavage of pre-
microRNA to mature microRNA. Germline DICER1 mutation results in DICER syndrome, a …
microRNA to mature microRNA. Germline DICER1 mutation results in DICER syndrome, a …
DICER1 Mutations Occur in More Than One-Third of Follicular-Patterned Pediatric Papillary Thyroid Carcinomas and Correlate with a Low-Risk Disease and Female …
Some pediatric papillary thyroid carcinoma (PPTC) cohorts have suggested a preliminary
correlation with respect to DICER1 mutation status and histomorphology in both benign and …
correlation with respect to DICER1 mutation status and histomorphology in both benign and …
Expanding Our Knowledge of DICER1 Gene Alterations and Their Role in Thyroid Diseases
MC Riascos, A Huynh, WC Faquin, V Nosé - Cancers, 2024 - mdpi.com
Simple Summary Mutations in DICER1, a gene involved in RNA interference, have been
associated with a wide range of multi-organ neoplastic and non-neoplastic conditions …
associated with a wide range of multi-organ neoplastic and non-neoplastic conditions …
On the chopping block: overview of DICER1 mutations in endocrine and neuroendocrine neoplasms
CC Juhlin - Surgical Pathology Clinics, 2023 - surgpath.theclinics.com
Mutational inactivation of the DICER1 gene causes aberrant micro-RNA maturation, which in
turn may have consequences for the posttranscriptional regulation of gene expression …
turn may have consequences for the posttranscriptional regulation of gene expression …
Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: Systematic review
MSA de Sousa, IN Nunes, YP Christiano… - Reviews in Endocrine …, 2024 - Springer
Differentiated thyroid cancer (DTC) is a rare disease in the paediatric population (≤ 18
years old. at diagnosis). Increasing incidence is reflected by increases in incidence for …
years old. at diagnosis). Increasing incidence is reflected by increases in incidence for …
Molecular landscape of pediatric thyroid cancer: a review
P Guleria, R Srinivasan, C Rana, S Agarwal - Diagnostics, 2022 - mdpi.com
Thyroid carcinomas (TC) are rare in the pediatric population; however, they constitute the
most common endocrine malignancy. Despite some similarities with adult carcinomas, they …
most common endocrine malignancy. Despite some similarities with adult carcinomas, they …
Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors
E Minna, A Devecchi, F Pistore, B Paolini… - Frontiers in …, 2023 - frontiersin.org
Background Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer
(TC). Several genomic and transcriptomic studies explored the molecular landscape of …
(TC). Several genomic and transcriptomic studies explored the molecular landscape of …